Jayanth Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Jayanth Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, gr…

2002-01-31 Hyderabad, Telangana Active Unlisted Active Compliant
Share
JP Jayanth Pharmaceuticals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Jayanth Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
86/100
Trust Score
Low Risk

Jayanth Pharmaceuticals Private Limited is assessed as Low Risk with a Trust Score of 86/100. Jayanth Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2002, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Jayanth Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
86/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 3 open (25.19 cr) · 14 satisfied (12.24 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Indian Bank4 48.0 cr
Others6 48.0 cr
Axis Bank Limited4 48.0 cr
Andhra Pradesh State Financial Corporation1 48.0 cr
Hdfc Bank Limited1 48.0 cr
Mrs. Manju Sethia W/O Umachand Sathia1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
RAVI TEJA REDDY BAIREDDY 01234567 Director 01/04/2018 6 yrs Approved
NITYA DASARAM 01234567 Director 01/04/2018 6 yrs Approved
KOTI REDDY BAIREDDY 01234567 Director 01/04/2018 6 yrs Approved
BAIREDDY JAYA 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • RAVI TEJA REDDY BAIREDDY has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 5 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: RAVI TEJA REDDY BAIREDDY (Whole-time director) · NITYA DASARAM (Whole-time director) · KOTI REDDY BAIREDDY (Managing Director) · BAIREDDY JAYA (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
EPFO headcount growing - hiring signal.
Operating for 24+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
3 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence93/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 25.19 cr already registered.
  • Compliance record supports lending.
Investor view86/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
21 Aug 2025
Charge satisfied
Axis Bank Limited
31 Mar 2025
Latest balance sheet
Filed with ROC
24 May 2023
Charge satisfied
Others
31 Mar 2023
Charge created
Indian Bank - 8.20 cr
19 Oct 2022
Charge created
Indian Bank - 16.88 cr
03 Oct 2022
Charge satisfied
Others
31 May 2022
Charge created
Hdfc Bank Limited - 11.73 Lakh
27 Dec 2021
Charge satisfied
Axis Bank Limited
25 Oct 2021
Charge created
Others - 3.25 cr
25 Sep 2021
Charge created
Others - 1.35 cr
16 Aug 2021
Charge created
Axis Bank Limited - 36.79 Lakh
16 Mar 2021
Charge satisfied
Others
18 Feb 2021
Charge satisfied
Indian Bank
17 Feb 2021
Charge satisfied
Others
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Debt-to-equity stands at 2.1x - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Andreas Pharma Private Limited U36999MH2017PTC300287 Vasai, Maharashtra, India
Refcoat Chemicals Private Limited U24233KA2015PTC084876 Tumkur, Karnataka, India
A R K Health Care Pvt Ltd U24299CH1997PTC020705 Manimajra, Chandigarh, India
Uttaranchal Terpene Products Private Limited U24115UR2001PTC025944 Uttranchal, Uttarakhand, India
Atc Paints Private Limited U24220TG2014PTC093803 Hyderabad, Telangana, India
Arosol Chemicals Private Limited U24112UP1987PTC008667 Saharanpur, Uttar Pradesh, India
Ayush Chemopharma Private Limited U24100GJ2010PTC061260 Ankleshwar, Gujarat, India
Autograde Industries Private Limited U74999KL2017PTC050142 Ernakulam, Kerala, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Jayanth Pharmaceuticals Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Jayanth Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Jayanth Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Jayanth Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Jayanth Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Jayanth Pharmaceuticals Private Limited an active company?

Jayanth Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Jayanth Pharmaceuticals Private Limited financially healthy?

Jayanth Pharmaceuticals Private Limited has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Jayanth Pharmaceuticals Private Limited?

Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Jayanth Pharmaceuticals Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Jayanth Pharmaceuticals Private Limited have loans or charges against its assets?

3 open charge(s) are registered against its assets, and 14 earlier charge(s) stand satisfied.

Is Jayanth Pharmaceuticals Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Jayanth Pharmaceuticals Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.